Status:
COMPLETED
Transforming Opioid Prescribing in Primary Care
Lead Sponsor:
Boston Medical Center
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Chronic Pain
Opioid-Related Disorders
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Prescription opioid misuse is a significant public health problem as well as a patient safety concern. Primary care providers are the leading prescribers of opioids for chronic pain, yet few providers...
Detailed Description
This project will implement interventions in the primary care setting to improve management of patients prescribed opioid therapy for chronic non-cancer pain. Prescription opioid misuse is a signific...
Eligibility Criteria
Inclusion
- All PCPs (physicians, doctors of osteopathy, nurse practitioners, and physicians' assistants) at participating sites with 4 patients prescribed opioid treatment along with their patients greater than or equal to age 18 who have 1) 3 or more completed visits to the primary care practice; 2) long-term opioid treatment defined by 3 or more opioid prescriptions written at least 21 days apart within 6 months; and 3) an inpatient or outpatient ICD9CM diagnosis for musculoskeletal or neuropathic pain. In addition, non-PCP staff at the health centers and at the Massachusetts State PMP who agree to be included in the qualitative assessments will be included and will be considered subjects. Note that the investigators have limited inclusion in the study to PCPs with at least 4 patients on chronic opioid therapy because it was determined that for PCPs with fewer than 4 patients the time burden associated with the study (meeting with nurse care manager, receiving academic detailing etc) would not be justified.
Exclusion
- Patients currently receiving care for cancer, except non-melanoma skin cancer. Patients with remote (\>5 years) histories being disease-free from other cancers (e.g. breast, colon, prostate) will not be excluded due to the low risk of current cancer related pain. PCPs and staff who do not consent to the study.
Key Trial Info
Start Date :
January 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2016
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT01909076
Start Date
January 1 2014
End Date
March 1 2016
Last Update
March 3 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Medical Center
Boston, Massachusetts, United States, 02118